Helix Acquisition and BridgeBio Oncology receive SEC approval for merger

Go back to Helix Acquisition and BridgeBio Oncology receive SEC approval for merger
(NASDAQ: BBIO) Delayed: 77.19 +2.67 (3.58%)
Previous Close $74.52    52 Week High
Open $75.03    52 Week Low
Day High $77.26    P/E N/A 
Day Low $74.49    EPS
Volume 3,179,471       

(NASDAQ: HLXB) Delayed: 9.90 --0 (-0%)
Previous Close $9.90    52 Week High
Open $9.90    52 Week Low
Day High $9.90    P/E N/A 
Day Low $9.90    EPS
Volume 355,929